Genmab A/S ADS Earnings Dividend

Genmab A/S ADS’s revenue jumped 24.89% since last year same period to $1155Mn in the Q2 2026. On a quarterly growth basis, Genmab A/S ADS has generated 28.43% jump in its revenue since last 3-months.

Genmab A/S ADS’s net profit fell -9.8% since last year same period to $303Mn in the Q2 2026. On a quarterly growth basis, Genmab A/S ADS has generated 469.59% jump in its net profits since last 3-months.

Genmab A/S ADS’s net profit margin fell -27.78% since last year same period to 26.23% in the Q2 2026. On a quarterly growth basis, Genmab A/S ADS has generated 343.5% jump in its net profit margins since last 3-months.

Genmab A/S ADS’s earning per share (EPS) estimates for the current quarter stand at 0.35 - a -5.41% fall from last quarter’s estimates.

Genmab A/S ADS’s earning per share (EPS) estimates for the current year stand at 0.35.

Genmab A/S ADS’s earning per share (EPS) jumped 0% since last year same period to 0.54 in the Q2 2026. This indicates that the Genmab A/S ADS has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.